HN user

ralmeida

337 karma

[ my public key: https://keybase.io/ralmeidab; my proof: https://keybase.io/ralmeidab/sigs/k6XInXgk2cHfKvZpbMDSOgc1rY0zNQP4HV90ABBt7is ]

Posts3
Comments265
View on HN

Not a definitive list, but do look around on which titles other companies are using. One way to do that is through career ladders - the Dropbox one was already mentioned in this thread, but take a look at https://progression.fyi/ and https://www.levels.fyi/ for a compilation of other examples.

Another way is to take a look around LinkedIn and see what titles other companies are doing (especially ones in the same talent market as you). Look both in the titles of current/past employees and in the job postings themselves.

Probably some combination of security theater and well-intentioned but shallow, nearsighted and misguided attempt to increase security by reducing a perceived attackable surface area (i.e. likely somebody got scared with "View source" or something like that).

If someone has access to your laptop with a logged-in Gmail account, they could change your password and log you out of your other devices, effectively gaining total control of your account and locking you out.

if health care professionals were missing PPE as a result

True, but "don't buy masks NOW because the health workers need them" is totally different than "don't buy masks because they are not effective for the general public and can actually be worse" - being either a terribly wrong idea (like the article defends) or outright lying to the public (if the message was told not because it was believed to be true, but as a roundabout way of being extra emphatic to avoid the public hoarding masks and causing PPE shortages for health workers).

Maybe wikipedia also changed it (did you check?)

Here's a link to the Wikipedia entry from 2017, same text: https://en.wikipedia.org/w/index.php?title=Vaccine&oldid=798...

Here's a link to the CDC definition from 2017: https://web.archive.org/web/20171203162427/https://www.cdc.g... ("Vaccine: A product that stimulates a person’s immune system to produce immunity to a specific disease, protecting the person from that disease.")

It's all marketing at this point.

Definitions made prior to the pandemic would already fit the mRNA vaccines, therefore the claim that the definition was stretched for marketing/persuasion reasons don't really hold water.

Not FDA approved in the US. "approval pending"

This FDA link claims Cominarty was approved in August 23 2021. The word "pending" is not found in this page.

https://www.fda.gov/news-events/press-announcements/fda-appr...

These kind of drugs take years to develop. This stuff was done in a few months.

"The first human clinical trials using an mRNA vaccine against an infectious agent (rabies) began in 2013." (from https://en.wikipedia.org/wiki/MRNA_vaccine)

Of course the actual individual version for COVID-19 is newer, but then again, so is any flu vaccine that is updated basically yearly. What matters is the age of the "vaccine platform".

They skipped some steps in the process.

Citation needed?

Fair enough, but in many cases some attendees attend only by inertia and would be better off declining instead anyway. Which is probably good overall if the meeting is indeed "stupid".

And yet your own linked study says, right in the first paragraph, that vaccinated contacts got it 38% less often.

Is it possible that this is not enough, and “virtually everyone will eventually be exposed”? Yes. Is it possible that COVID will become endemic and many (but not all or even most) people will be exposed? Yes. Have I seen any source that makes a strong case for this? Not yet.

Wikipedia defines "vaccine" as "a biological preparation that provides active acquired immunity to a particular infectious disease", which in my view would fit the Pfizer/Moderna shots. Which definition of "vaccine" do you subscribe to that these "treatments" don't fit into?

Also, mRNA is not the only type of vaccine for COVID.

Finally, two more questions: would you clarify which definition of "experimental" you subscribe to? And do you have a source for "testing standards were reduced"?

From a "reducing my risk of dying" perspective, you'd have to balance the risk of dying from taking the vaccine vs the risk of dying from COVID with zero treatments, one treatment, or both treatments.

The numbers could lean either way and would be very sensitive to variations in the probabilities involved - I'm sure it would be very hard to reach any form of consensus on "probability of dying from taking the vaccine". It's also worth addressing wasn't even making the point of which (so-called) experimental treatment has a better likely outcome but rather addressing criticism at (so-called) experimental treatments in general.

From an "unknown risk" perspective, you'd also have to consider that COVID itself could have yet-unknown long-term risks.

It wouldn't be necessarily illogical but would still qualify as "taking part in an experiment trial", as put by the parent post.

To determine if this is a rational strategy or not, we'd have to get real numbers (is it really likely that 1 in 100k people die from taking the vaccine?), and compare that against the reduction in probability of dying from COVID by even combining both treatments.

Which is a fair viewpoint from the societal level, but not as much for the individual level, which was implied in the parent message - i.e. how can "I'll take experimental treatment B instead of experimental treatment A" be an argument for not taking experimental treatments in general?

In Portuguese, it's _Uma lagarta muito comilona_ according to Amazon - something like "A very guzzling cartepillar"

Architecture.md 5 years ago

Sounds right to me too. One quicker way to improve the 'first process' is to change only step one - do not spend a long time, but instead write a few paragraphs with what's most important and/or top-of-mind. Often, this opens the door to more contributions and questions.

Of course, update accordingly whenever you find yourself in a discussion about something with a contributor (no matter if the architecture doc is even part of the discussion or not).

There's Provisioned Concurrency for Lambda which keeps an amount of Lambdas warm at a price, so you don't have to keep pinging your function yourself to pre-heat.

Exactly! Other non-scalability concerns they address (specifically talking about Kubernetes here) is a primitive amount of monitoring/observability; no-downtime updates (rolling updates); liveness/readiness probes; primitive service discovery and load balancing; resiliency to any one single host failing (even if the total compute power could easily fit into a single bigger server).

Agree, a job title of “DevOps Engineer” is an organizational smell for me.

Most people with such a title are actually something like “Automation Engineers”, “Infrastructure Engineers”, “Operations Engineers”, “Site Reliability Engineers”, etc, that are involved in a DevOps “process”, “initiative”, “culture”, etc.